Long-term adverse cardiovascular changes induced by cocoa shell extract administration through lactation in fetal...

Cocoa shell extract (CSE; rich in antioxidant compounds) administered to adult hypertensive rats exposed to fetal undernutrition (MUN) reduces blood pressure, improving cardiovascular alterations. We aimed to explore lactation as a reprogramming window, evaluating the long-term effects of CSE supplementation during this period. MUN and control (C) dams were given 250 mg/kg/day CSE (5 days/week) or vehicle (VEH) in gelatine throughout lactation. Blood pressure (tail-cuff plethysmography), heart (echocardiography) and mesenteric resistance artery (MRA) function (wire myography) and structure (pressure myography, confocal microscopy) were studied in 8-month-old offspring. MUN-VEH rats had significantly higher blood pressure and reduced MRA internal diameter compared with C-VEH counterparts. MUN-VEH males also had smaller left ventricular mass index, acetylcholine, sodium nitroprusside relaxations and increased stiffness, whereas MUN-VEH females had elevated maximal noradrenaline-evoked contractions. CSE administration led to lower body weight in most groups and a lower blood pressure in MUN-CSE, but not C-CSE rats, compared with non-treated counterparts. Supplementation reduced left ventricular mass index, heart rate and ejection fraction in all groups and worsened MRA acetylcholine-mediated vasodilatation in MUN-CSE females and C-CSE males and females. CSE induced medial layer hypertrophy in all groups; it increased internal diameter only in MUN-CSE rats and it elevated wall-to-lumen ratio in C-CSE rats. In conclusion, although CSE supplementation during lactation prevented the development of hypertension in MUN rats, the induced cardiovascular functional and structural alterations, particularly in control offspring, suggest detrimental effects of CSE bioactive components, at least at the dose used. This study highlights the need for caution when administering supplements during lactation.